Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.

Key Takeaways A higher-than-anticipated report on consumer inflation sent U.S. equities lower at midday.Solar power company ...

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The ...

Barclays upgraded CVS Health Corp (NYSE: CVS) shares to Overweight from Equal Weight, citing a promising outlook for the ...

Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026, ...

NEW YORK (Reuters) - The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug ...

On the other hand, Barclays holds an Equal Weight ... PBM assets remains crucial to its valuation. CVS operates three primary segments: Health Services (which includes its Pharmacy Benefit Manager ...

Barclays will no longer be a partner of The Great Escape Festival in 2025, after over 125 artists boycotted the event this year. More than a quarter of the Brighton festival’s lineup pulled out ...

Barclays CDs offer some of the highest yields in the country. With no opening deposit and plenty of term lengths, it’s a great option if you’re looking for a way to safely grow your savings ...

A Barclays customer was left scratching their head after being informed they would need to make a trip to another town to deposit some coins. The unhappy bank user reached out to Barclays through ...